6 news items
HEALWELL AI's Pentavere Announces Partnership with Takeda to Support Rare Disease Real-World Evidence Analysis for Patients living with Hereditary Angioedema
TAK
6 Jun 24
to extract actionable insights that can inform treatment strategies and improve patient outcomes. A manuscript and an abstract on the PROSPECT study data
Blackstone Weighs Sale Of Japanese Pharma Firm Alinamin: Report
BX
TAK
3 Jun 24
.
Blackstone acquired Alinamin from Takeda for ¥242 billion in 2021 as part of Takeda’s asset disposal strategy following its $62 billion purchase
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease
ACIU
TAK
13 May 24
historical fact and may include statements that address future operating, financial or business performance or AC Immune's strategies or expectations
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease
ACIU
TAK
13 May 24
or business performance or AC Immune's strategies or expectations. In some cases, you can identify these statements by forward-looking words such as "may
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
TAK
26 Apr 24
outcomes and limited treatment options. Some patients with metastatic CRC may benefit from personalized therapeutic strategies based on molecular
85yg11khp7 dix
TAK
22 Apr 24
)In this press release, statements made with respect to current plans, estimates, strategies and beliefs and other
- Prev
- 1
- Next